Clinical Trial Update: Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of Hepalatide (L47) in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepalatide (L47) (Hepalatide)

Snippet

Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. | Conditions: Hepatitis B， Chronic | Phase 1 | Status: COMPLETED